#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cytomegalovirus infection Transitional cell carcinoma Gastroenteropancreatic neuroendocrine tumour disease Immune-mediated enterocolitis Tourette's disorder Niemann-Pick disease Drug eruption Hyperphagia Candida infection Colon cancer Vaginal cancer Methylmalonic acidaemia Breast cancer metastatic Retinopathy of prematurity Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Treatment Primary biliary cholangitis – Basic Information Leiomyosarcoma recurrent – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Alexander disease – Life with Disease Chondrosarcoma metastatic – Trials in Disease Primary immunodeficiency syndrome – Treatment Alternating hemiplegia of childhood Hepatic angiosarcoma – Diagnostics Krabbe’s disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ht-29-A Piperacillin Monohydrate Decitabine Gsk4381562A Pantothenate Sodium Serine Sultiame NALMEFENE HYDROCHLORIDE Mosaic Hbcoreag FOSFOMYCIN CALCIUM Immunoglobulin G Acetazolamide Copper (64Cu) Chloride Interferon Beta-1A SOFTISAN 378 AB521 OXYBUTYNIN HYDROCHLORIDE ALN-4324 Chlorambucil Regn7257 More therapies…

    Learn about Your Condition

    Pulmonary embolism Genital infection female Mitochondrial DNA depletion Eosinophilic oesophagitis Infective uveitis Skin neoplasm excision Stevens-Johnson syndrome Osteochondrodysplasia Soft tissue sarcoma Metastatic glioma B-cell type acute leukaemia Wolfram syndrome Inclusion body myositis Acute kidney injury Metastatic malignant melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • ADMILPARANT
    Austria Belgium Czechia Denmark Finland France +9

  • A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Testicular germ cell cancer
    • Cervix carcinoma
    • Endometrial cancer
    Investigated Drugs:
    • SGN-ALPV
    Denmark The Netherlands Spain Sweden

  • Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Temozolomide
    Denmark France Germany Ireland Italy The Netherlands +2

  • Testing Personalized Drug Combination Treatment to Reduce Deaths in Patients with Severe Acute Infections

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infection
    Investigated Drugs:
    • Acetylcysteine
    • Ferric Derisomaltose
    • Hydrocortisone
    Denmark

  • Study of Drug Combination with Pembrolizumab Guided by Blood Biomarkers for Patients with Metastatic Non-Small Cell Lung Cancer

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Lung cancer metastatic
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    Italy

  • A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Cachexia
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Ponsegromab
    Belgium Bulgaria France Germany Italy Poland +2
Previous Page
1 … 741 742 743 744 745 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!